Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin plus calcium chloride to reduce blood loss in abdominal myomectomy
IRCT20110712007013N23Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin and calcium chloride in Fibromyoma (LM), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Intraoperative blood loss. Started May 2018; status: completed.
02
Drugs
oxytocincalcium chloride
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20110712007013N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110712007013N23.